In particular, T1150A in NSD2 is one of the frequent somatic cancer mutants and the corresponding T1232A mutation in NSD3 has been shown before to be a driver mutant which increases cell proliferation and xenograft tumor growth (35). Here, NSD2 is linked to cancer.